戻る 戻る
細胞番号 : 細胞名
RCB2145 : PC-3  update : 2024/06/10
細胞特性(Comment:英)Human cell line derived from bone metastasis of prostatic cancer. TKG0600 (Deposited from Tohoku Univ.).
細胞特性(日)ヒト前立腺癌由来細胞株。骨転移巣より樹立。 TKG0600 (東北大学医用細胞資源センターからの寄託)。
使用条件(英)There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC.
提供申込書類(英) Order Form(C-0005.pdf)   MTA(C-0007.pdf)   MTA(C-0007p.pdf)  
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
提供申込書類(日) 依頼書C-0001.pdf   同意書(非営利学術目的)C-0003.pdf   同意書(営利目的)C-0003p.pdf  
提供同意書は、使用機関の種類や目的に応じて、非営利学術目的 (C-XXXX) と営利目的 (C-XXXXp) の2種類があります。該当する提供同意書をご使用ください(詳細)。特許等の取得及び商業利用等は事前に必ず cellbank.brc@riken.jp までご連絡ください。
提供手数料 手数料とお支払いについてはこちらをご覧ください。
細胞基本情報 寄託者 Obinata, Masuo
寄託日 2005
元の細胞 TKG0600
動物種 _human < Mammals
属名 Homo
種名 sapiens
人種 Caucasian
性別 Male
62 years
採取組織 prostate, bone meta
病名 prostatic carcinom
転移 Yes
転移巣 bone
細胞分類 cancer
入手歴 Cell Resource Center for Biomedical Research, Tohoku University(TKG0600)
細胞寿命 infinite
細胞形態 epithelial-like
Cellosaurus(Expasy) CVCL_0035
培地・試薬情報 培地・試薬一覧はこちらをご覧ください。
培養形態 Adherent cells
培地 RPMI1640 + 10% FBS
抗生物質 Free
継代方法 0.25% Trypsin
継代密度 1 : 8 split
継代・培地交換頻度 Subculture : 2 times/week
培養最適温度 37 ℃
二酸化炭素濃度 5 %
凍結培地 Medium + 10% DMSO
凍結方法 Slow freezing
マイコプラズマ (-)
アイソザイム検査 LD, NP
個体識別検査 OK
文献情報 Reference(英) 4件
Reference(日) 0件
利用者成果(英) 75件
利用者成果(日) 1件

5121  Kirk D, Szalay MF, Kaighn ME.  Modulation of growth of a human prostatic cancer cell line (PC-3) in agar culture by normal human lung fibroblasts.  Cancer Res  1981  41(3):1100-3  PubMed ID: 7459854  
5120  Ohnuki Y, Marnell MM, Babcock MS, Lechner JF, Kaighn ME.  Chromosomal analysis of human prostatic adenocarcinoma cell lines.  Cancer Res  1980  40(3):524-34  PubMed ID: 7471073  
5118  Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW.  Establishment and characterization of a human prostatic carcinoma cell line (PC-3).  Invest Urol  1979  17(1):16-23  PubMed ID: 447482  
5119  Kaighn ME, Lechner JF, Narayan KS, Jones LW.  Prostate carcinoma: tissue culture cell lines.  Natl Cancer Inst Monogr  1978  (49):17-21  PubMed ID: 571045  


21610  Kaneda-Nakashima K, Shirakami Y, Kadonaga Y, Watabe T, Ooe K, Yin X, Haba H, Shirasaki K, Kikunaga H, Tsukada K, Toyoshima A, Cardinale J, Giesel FL, Fukase K.  Comparison of Nuclear Medicine Therapeutics Targeting PSMA among Alpha-Emitting Nuclides.  Int J Mol Sci  2024  25(2)  PubMed ID: 38256007   DOI: 10.3390/ijms25020933
21737  Shiomi A, Kaneko T, Nishikawa K, Tsuchida A, Isoshima T, Sato M, Toyooka K, Doi K, Nishikii H, Shintaku H.  High-throughput mechanical phenotyping and transcriptomics of single cells.  Nat Commun  2024  15(1):3812  PubMed ID: 38760380   DOI: 10.1038/s41467-024-48088-5
19646  Ohya S, Kajikuri J, Kito H, Matsui M.  Down-Regulation of CYP3A4 by the KCa1.1 Inhibition Is Responsible for Overcoming Resistance to Doxorubicin in Cancer Spheroid Models  Int J Mol Sci  2023  24(21):15672  PubMed ID: 37958656   DOI: 10.3390/ijms242115672
19764  Yamashita SN, Tanaka Y, Kitagawa T, Baron B, Tokuda K, Paudel D, Nakagawa K, Ohta T, Hamada JI, Kobayashi M, Nagayasu H, Kuramitsu Y.  Down-regulating Effect of a Standardized Extract of Cultured Lentinula edodes mycelia on Cortactin in Prostate Cancer Cells Is Dependent on Malignant Potential  Anticancer Res  2023  43(3):1159-1166  PubMed ID: 36854514   DOI: 10.21873/anticanres.16261
21021  Hayashi Y, Kimura S, Yano E, Yoshimoto S, Saeki A, Yasukochi A, Hatakeyama Y, Moriyama M, Nakamura S, Jimi E, Kawakubo-Yasukochi T.  Id4 modulates salivary gland homeostasis and its expression is downregulated in IgG4-related disease via miR-486-5p.  Biochim Biophys Acta Mol Cell Res  2023  1870(2):119404  PubMed ID: 36535369   DOI: 10.1016/j.bbamcr.2022.119404
21112  Chingle RM, Imai M, Altman S, Saito D, Takahashi N, Burke TR.  Examination of aminophenol-containing compounds designed as antiproliferative agents and potential atypical retinoids.  Bioorg Med Chem  2023  82:117214  PubMed ID: 36913882   DOI: 10.1016/j.bmc.2023.117214
17648  Viet Hung T, Thang PNT, Hien HM, Diep VT, Thu NT, Tan DM, Pham DT, Thi Ha D, Huynh DTM.  Cytotoxic Activities and Fingerprint Analysis of Triterpenes by HPTLC Technique for Distinguishing Ganoderma Species from Vietnam and other Asian Countries  Plants (Basel)   2022  11(23):3397  PubMed ID: 36501435   DOI: 10.3390/plants11233397
17655  Ohya S, Matsui M, Kajikuri J, Kito H, Endo K.  Downregulation of IL-8 and IL-10 by the Activation of Ca2+-Activated K+ Channel KCa3.1 in THP-1-Derived M2 Macrophages  Int J Mol Sci  2022  23(15):8603  PubMed ID: 35955737   DOI: 10.3390/ijms23158603
18229  Ito S, Ueda T, Yokoyama A, Fujihara A, Hongo F, Ukimura O.  PCA3 controls chromatin organization and p53 signal activation by regulating LAP2α-lamin A complexes  Cancer Gene Ther  2022  29(3-4):358-368  PubMed ID: 33758375   DOI: 10.1038/s41417-021-00314-8
20582  Qian Y, Liu X, Feng Y, Li X, Xuan Y.  Tenascin C regulates cancer cell glycolysis and tumor progression in prostate cancer.  Int J Urol  2022    PubMed ID: 35218089   DOI: 10.1111/iju.14830
20668  Mitani F, Lin J, Sakamoto T, Uehara R, Hikita T, Yoshida T, Setiawan A, Arai M, Oneyama C.  Asteltoxin inhibits extracellular vesicle production through AMPK/mTOR-mediated activation of lysosome function.  Sci Rep  2022  12(1):6674  PubMed ID: 35461323   DOI: 10.1038/s41598-022-10692-0
16725  Hasegawa T, Ito M, Hasegawa S, Teranishi M, Takeda K, Negishi S, Nishiwaki H, Takeda JI, LeBaron TW, Ohno K.  Molecular Hydrogen Enhances Proliferation of Cancer Cells That Exhibit Potent Mitochondrial Unfolded Protein Response  Int J Mol Sci  2022  23(5):2888  PubMed ID: 35270030   DOI: 10.3390/ijms23052888
16730  Takagi H, Moyama C, Taniguchi K, Ando K, Matsuda R, Ando S, Ii H, Kageyama S, Kawauchi A, Chouha N, Désaubry L, Nakata S.  Fluorizoline Blocks the Interaction between Prohibitin-2 and γ-Glutamylcyclotransferase and Induces p21 Waf1/Cip1 Expression in MCF7 Breast Cancer Cells  Mol Pharmacol  2022  101(2):78-86  PubMed ID: 34862308   DOI: 10.1124/molpharm.121.000334
16741  Isaac Kingsley Amponsah, Gina Flor Ramos, Benjamin Kingsley Harley, Joseph Adusei Sarkodie, Edmund Ekuadzi, Elikplim Kwesi Ampofo, Inemesit Okon Ben  Anti-inflammatory, Antioxidant and Cytotoxic Activities of Guibourtia ehie on Human Prostate (PC-3) and Breast Cancer (MC-7) Cell Lines and in silico Studies on Its Metabolite 7,4′-Dihydroxyflavone  Chemistry Africa  2022  5:627-639    DOI: 10.1007/s42250-022-00359-8
16833  Tanaka Y, Kambayashi H, Yamamoto A, Onishi I, Sugita K, Matsumura M, Ishibashi S, Ikeda M, Yamamoto K, Kitagawa M, Kurata M.  Efficient Identification of the MYC Regulator with the Use of the CRISPR Library and Context-Matched Database Screenings  Int J Mol Sci  2022  23(14):7723  PubMed ID: 35887071   DOI: 10.3390/ijms23147723
17315  Watabe T, Kaneda-Nakashima K, Shirakami Y, Kadonaga Y, Ooe K, Wang Y, Haba H, Toyoshima A, Cardinale J, Giesel FL, Tomiyama N, Fukase K.  Targeted α-therapy using astatine (211At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound  Eur J Nucl Med Mol Imaging  2022  Nov 8  PubMed ID: 36344651   DOI: 10.1007/s00259-022-06016-z
13130  Sasaki K, Harada M, Yoshikawa T, Tagawa H, Harada Y, Yonemitsu Y, Ryujin T, Kishimura A, Mori T, Katayama Y.  Fc-Binding Antibody-Recruiting Molecules Targeting Prostate-Specific Membrane Antigen: Defucosylation of Antibody for Efficacy Improvement*.  Chembiochem  2021  22(3):496-500  PubMed ID: 32969164   DOI: 10.1002/cbic.202000577
13395  Imamura R, Kitagawa S, Kubo T, Irie A, Kariu T, Yoneda M, Kamba T, Imamura T.  Prostate cancer C5a receptor expression and augmentation of cancer cell proliferation, invasion, and PD-L1 expression by C5a.  Prostate  2021    PubMed ID: 33368414   DOI: 10.1002/pros.24090
20153  Yin X, Yamada S, Kobayashi H, Tanaka R, Togo Y, Hosoi M, Tsuchida M, Kunoh T, Wada S, Nakamura T, Sasaki R, Mizukami T, Hasegawa M.  Expression and cell transformation activity of dynactin-associated protein isoforms.  FEBS Open Bio  2021    PubMed ID: 34043884   DOI: 10.1002/2211-5463.13202
20249  Makise M, Uchimura R, Higashi K, Mashiki Y, Shiraishi R, Shutoku Y, Kuniyasu A.  Overexpression of the nucleoporin Nup88 stimulates migration and invasion of HeLa cells.  Histochem Cell Biol  2021    PubMed ID: 34331103   DOI: 10.1007/s00418-021-02020-w
16701  Chinen T, Yamazaki K, Hashimoto K, Fujii K, Watanabe K, Takeda Y, Yamamoto S, Nozaki Y, Tsuchiya Y, Takao D, Kitagawa D.  Centriole and PCM cooperatively recruit CEP192 to spindle poles to promote bipolar spindle assembly  J Cell Biol  2021  220(2):e202006085  PubMed ID: 33443571   DOI: 10.1083/jcb.202006085
17030  Uwada J, Mukai S, Terada N, Nakazawa H, Islam MS, Nagai T, Fujii M, Yamasaki K, Taniguchi T, Kamoto T, Yazawa T.  Pleiotropic effects of probenecid on three-dimensional cultures of prostate cancer cells  Life Sci  2021  278:119554  PubMed ID: 33932444   DOI: 10.1016/j.lfs.2021.119554
17032  Kazuko KANEDA-NAKASHIMA, Zijian ZHANG, Kojiro NAGATA, Kenji SHIRASAKI, Hidetoshi KIKUNAGA, Tomoo YAMAMURA, Kazuhiro OOE, Tadashi WATABE, Atsushi TOYOSHIMA, Takashi YOSHIMURA, Atsushi SHINOHARA  Dispersion of Alpha-Nuclides during Animal Experiments  Radiation Safety Management  2021  20:29-38    DOI: 10.12950/rsm.210519
19498  Kohno S, Linn P, Nagatani N, Watanabe Y, Kumar S, Soga T, Takahashi C.  Pharmacologically targetable vulnerability in prostate cancer carrying RB1-SUCLA2 deletion  Oncogene  2020  39(34):5690-5707  PubMed ID: 32694611   DOI: 10.1038/s41388-020-1381-6
9833  Keiichi Oono, Kazuo Ohtake, Chie Watanabe, Sachiko Shiba, Takashi Sekiya, Keizo Kasono  Contribution of Pyk2 Pathway and Reactive Oxygen Species (ROS) to the Anti-Cancer Effects of Eicosapentaenoic Acid (EPA) in PC3 Prostate Cancer Cells  Lipids Health Dis  2020  19(1):15  PubMed ID: 32005121   DOI: 10.1186/s12944-019-1122-4
12088  Nagasawa M, Tomimatsu K, Terada K, Kondo K, Miyazaki K, Miyazaki M, Motooka D, Okuzaki D, Yoshida T, Kageyama S, Kawamoto H, Kawauchi A, Agata Y.  Long non-coding RNA MANCR is a target of BET bromodomain protein BRD4 and plays a critical role in cellular migration and invasion abilities of prostate cancer.  Biochem. Biophys. Res. Commun.  2020    PubMed ID: 32199616   DOI: 10.1016/j.bbrc.2020.03.043
12152  Shogo Nomura, Yasuko Egawa, Sayaka Urano, Tsuyoshi Tahara, Yasuyoshi Watanabe & Katsunori Tanaka  Cancer discrimination by on-cell N-glycan ligation  Communications Chemistry  2020    PubMed ID: 36703447   DOI: 10.1038/s42004-020-0270-9
10510  Kenward Vong, Tomoya Yamamoto, Tsung-che Changa and Katsunori Tanaka   Bioorthogonal release of anticancer drugs via gold-triggered 2-alkynylbenzamide cyclization  Chemical Science  2020  11:10928-10933  PubMed ID: 34094342   DOI: 10.1039/D0SC04329J
13198  Hiromi I, Nakata S, Uenishi J.  Up-regulation of Death Receptor 5/TRAIL-R2 Mediates Apoptosis Induced by N,N'-[(3,4-dimethoxyphenyl)methylene] Biscinnamide in Cancer Cells.  Anticancer Res  2020    PubMed ID: 32878791   DOI: 10.21873/anticanres.14506
13264  Hikita T, Miyata M, Watanabe R, Oneyama C.  In vivo imaging of long-term accumulation of cancer-derived exosomes using a BRET-based reporter.  Sci Rep  2020    PubMed ID: 33024173   DOI: 10.1038/s41598-020-73580-5
13303  Uwada J, Nakazawa H, Mikami D, Islam MS, Muramatsu I, Taniguchi T, Yazawa T.  PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptor, directly inhibits p38 MAPK.  Biochem Pharmacol  2020    PubMed ID: 33132165   DOI: 10.1016/j.bcp.2020.114297
13317  Fujita K, Kamiya M, Yoshioka T, Ogasawara A, Hino R, Kojima R, Ueo H, Urano Y.  Rapid and Accurate Visualization of Breast Tumors with a Fluorescent Probe Targeting α-Mannosidase 2C1.  ACS Cent Sci  2020    PubMed ID: 33376783   DOI: 10.1021/acscentsci.0c01189
13591  Saiki I, Yara M, Yamanaka T, Uchino H, Inazu M.  Functional Expression of Choline Transporter-Like Protein 1 in LNCaP Prostate Cancer Cells: A Novel Molecular Target  Biomol Ther (Seoul)  2020  28(2):195-201  PubMed ID: 31693854   DOI: 10.4062/biomolther.2019.097
13771  F. Sima, H. Kawano, A. Miyawaki, K. Obata, D. Serien, K. Sugioka  3D glass nanofluidics fabricated by femtosecond laser processing for study of cancer cell metastasis and invasion  SPIE LASE  2020      DOI: 10.1117/12.2547222
11271  Itoh A, Nonaka Y, Ogawa T, Nakamura T, Nishi N.  Galectin-9 induces atypical ubiquitination leading to cell death in PC-3 prostate cancer cells.  Glycobiology  2019    PubMed ID: 30383222   DOI: 10.1093/glycob/cwy099
11464  Ishigami-Yuasa M, Ekimoto H, Kagechika H.  Class IIb HDAC Inhibition Enhances the Inhibitory Effect of Am80, a Synthetic Retinoid, in Prostate Cancer.  Biol. Pharm. Bull.  2019    PubMed ID: 30828077   DOI: 10.1248/bpb.b18-00782
11507  Murata K, Saga R, Monzen S, Tsuruga E, Hasegawa K, Hosokawa Y.  Understanding the mechanism underlying the acquisition of radioresistance in human prostate cancer cells.  Oncol Lett  2019    PubMed ID: 31186811   DOI: 10.3892/ol.2019.10219
11639  Taniguchi K, Ii H, Kageyama S, Takagi H, Chano T, Kawauchi A, Nakata S.  Depletion of gamma-glutamylcyclotransferase inhibits cancer cell growth by activating the AMPK-FOXO3a-p21 axis.  Biochem. Biophys. Res. Commun.  2019    PubMed ID: 31345573   DOI: 10.1016/j.bbrc.2019.07.049
11800  Koizumi A, Narita S, Nakanishi H, Ishikawa M, Eguchi S, Kimura H, Takasuga S, Huang M, Inoue T, Sasaki J, Yoshioka T, Habuchi T, Sasaki T.  Increased fatty acyl saturation of phosphatidylinositol phosphates in prostate cancer progression.  Sci Rep  2019    PubMed ID: 31520002   DOI: 10.1038/s41598-019-49744-3
11807  Takagi H, Ii H, Kageyama S, Hanada E, Taniguchi K, Yoshiya T, Chano T, Kawauchi A, Nakata S.  Blockade of γ-Glutamylcyclotransferase Enhances Docetaxel Growth Inhibition of Prostate Cancer Cells.  Anticancer Res.  2019    PubMed ID: 31519583   DOI: 10.21873/anticanres.13666
11717  K Hayashi et al  Optimization of Surface Treatment of MEMS Probes for Single-cell Capture and Release  Sensors and Materials  2019  31(9):2873    DOI: 10.18494/SAM.2019.2322
13859  Park J, Komori T, Uda T, Miyajima K, Fujii T, Kim SH.  Sequential Cell-Processing System by Integrating Hydrodynamic Purification and Dielectrophoretic Trapping for Analyses of Suspended Cancer Cells  Micromachines (Basel)  2019  11(1):47  PubMed ID: 31905986   DOI: 10.3390/mi11010047
18197  Ii H, Yoshiya T, Nakata S, Taniguchi K, Hidaka K, Tsuda S, Mochizuki M, Nishiuchi Y, Tsuda Y, Ito K, Kageyama S, Yoshiki T.  A Novel Prodrug of a γ-Glutamylcyclotransferase Inhibitor Suppresses Cancer Cell Proliferation in vitro and Inhibits Tumor Growth in a Xenograft Mouse Model of Prostate Cancer  ChemMedChem  2018  13(2):155-163  PubMed ID: 29316360   DOI: 10.1002/cmdc.201700660
10845  Taniguchi K, Matsumura K, Ii H, Kageyama S, Ashihara E, Chano T, Kawauchi A, Yoshiki T, Nakata S.  Depletion of gamma-glutamylcyclotransferase in cancer cells induces autophagy followed by cellular senescence.  Am J Cancer Res  2018  8:650-661  PubMed ID: 29736310  
11105  Senga S, Kobayashi N, Kawaguchi K, Ando A, Fujii H.  Fatty acid-binding protein 5 (FABP5) promotes lipolysis of lipid droplets, de novo fatty acid (FA) synthesis and activation of nuclear factor-kappa B (NF-κB) signaling in cancer cells.  Biochim Biophys Acta Mol Cell Biol Lipids  2018  1863(9):1057-1067  PubMed ID: 29906613   DOI: 10.1016/j.bbalip.2018.06.010
11160  Languon S, Tuffour I, Quayson EE, Appiah-Opong R, Quaye O.  In Vitro Evaluation of Cytotoxic Activities of Marketed Herbal Products in Ghana.  J Evid Based Integr Med  2018    PubMed ID: 30088418   DOI: 10.1177/2515690X18790723
4319  Liu Q, Wu Y, Seino H, Haga T, Yoshizawa T, Morohashi S, Kijima H.  Correlation between DEC1/DEC2 and epithelial‑mesenchymal transition in human prostate cancer PC‑3 cells.  Mol Med Rep  2018    PubMed ID: 30106153   DOI: 10.3892/mmr.2018.9367
14599  Senga S, Kawaguchi K, Kobayashi N, Ando A, Fujii H.  A novel fatty acid-binding protein 5-estrogen-related receptor α signaling pathway promotes cell growth and energy metabolism in prostate cancer cells  Oncotarget  2018  9(60):31753-31770  PubMed ID: 30167092   DOI: 10.18632/oncotarget.25878
7050  Kajiura K, Masuda K, Naruto T, Kohmoto T, Watabnabe M, Tsuboi M, Takizawa H, Kondo K, Tangoku A, Imoto I.  Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.  Oncotarget  2017  8:2890-2905  PubMed ID: 27926516   DOI: 10.18632/oncotarget.13761
10506  Doi H, Kida T, Nishino K, Nakatsuji M, Sakamoto S, Shimizu S, Teraoka Y, Tamura Y, Kataoka Y, Inui T.  Solubility-Improved 10-O-Substituted SN-38 Derivatives with Antitumor Activity.  ChemMedChem  2017  12:1715-1722  PubMed ID: 28891271   DOI: 10.1002/cmdc.201700454
10973    Dynamics of Morphological Changes of Adherent Cultured Cells at a Range of Low Temperatures near Physiological Temperature (Time-Lapse Imaging by Digital Holographic Microscopy)  Cryobiology and Cryotechnology  2017  63, 45~51    DOI: 10.20585/cryobolcryotechnol.63.1_45
4534  Cui C, Hanyu M, Hatori A, Zhang Y, Xie L, Ohya T, Fukada M, Suzuki H, Nagatsu K, Jiang C, Luo R, Shao G, Zhang M, Wang F.  Synthesis and evaluation of [64Cu]PSMA-617 targeted for prostate-specific membrane antigen in prostate cancer.  Am J Nucl Med Mol Imaging  2017  7(2):40-52  PubMed ID: 28533936  
14574  Shaoyi Chen, Stelios Florinas, Abigail Teitgen, Ze-Qi Xu, Changshou Gao, Herren Wu, Kazunori Kataoka, Horacio Cabral, R. James Christie  Controlled Fab installation onto polymeric micelle nanoparticles for tuned bioactivity  Science and Technology of Advanced Materials  2017  18:666-680    DOI: 10.1080/14686996.2017.1370361
9615  Ohya S, Kanatsuka S, Hatano N, Kito H, Matsui A, Fujimoto M, Matsuba S, Niwa S, Zhan P, Suzuki T, Muraki K.  Downregulation of the Ca(2+)-activated K(+) channel KC a3.1 by histone deacetylase inhibition in human breast cancer cells.  Pharmacol Res Perspect  2016  4:e00228  PubMed ID: 27069638   DOI: 10.1002/prp2.228
9862  Sakura Y, Tsuboi K, Uyama T, Zhang X, Taoka R, Sugimoto M, Kakehi Y, Ueda N.  A quantitative study on splice variants of N-acylethanolamine acid amidase in human prostate cancer cells and other cells.  Biochim. Biophys. Acta  2016  1861:1951-1958  PubMed ID: 27693242   DOI: 10.1016/j.bbalip.2016.09.018
10024  Matsumura K, Nakata S, Taniguchi K, Ii H, Ashihara E, Kageyama S, Kawauchi A, Yoshiki T.  Depletion of γ-glutamylcyclotransferase inhibits breast cancer cell growth via cellular senescence induction mediated by CDK inhibitor upregulation.  BMC Cancer  2016  16:748  PubMed ID: 27658708   DOI: 10.1186/s12885-016-2779-y
10908    Extracts of Codiaeum variegatum (L.) A. Juss is Cytotoxic on Human Leukemic, Breast and Prostate Cancer Cell Lines  Journal of Applied Pharmaceutical Science  2016  6, 087-093    DOI: 10.7324/JAPS.2016.601114
6034  Liu Q, Wu Y, Yoshizawa T, Yan X, Morohashi S, Seino H, Kato Y, Kijima H.  Basic helix-loop-helix transcription factor DEC2 functions as an anti-apoptotic factor during paclitaxel-induced apoptosis in human prostate cancer cells.  Int J Mol Med  2016  38(6):1727-1733  PubMed ID: 27840924   DOI: 10.3892/ijmm.2016.2798
12610  Zhang B, Shimada Y, Hirota T, Ariyoshi M, Kuroyanagi J, Nishimura Y, Tanaka T.  Novel immunologic tolerance of human cancer cell xenotransplants in zebrafish  Transl Res  2016  170:89-98.e3  PubMed ID: 26746804   DOI: 10.1016/j.trsl.2015.12.007
12621  Okada T, Uto K, Aoyagi T, Ebara M.  A biomimetic approach to hormone resistant prostate cancer cell isolation using inactivated Sendai virus (HVJ-E)  Biomater Sci  2016  4(1):96-103  PubMed ID: 26553555   DOI: 10.1039/c5bm00375j
12660  Thangavel S, Yoshitomi T, Sakharkar MK, Nagasaki Y.  Redox nanoparticle increases the chemotherapeutic efficiency of pioglitazone and suppresses its toxic side effects  Biomaterials  2016  99:109-23  PubMed ID: 27235996   DOI: 10.1016/j.biomaterials.2016.05.001
12452  Kim SH, Fujii T.  Efficient analysis of a small number of cancer cells at the single-cell level using an electroactive double-well array  Lab Chip  2016  16(13):2440-9  PubMed ID: 27189335   DOI: 10.1039/c6lc00241b
14141  Nara T, Narita S, Mingguo H, Yoshioka T, Koizumi A, Numakura K, Tsuruta H, Maeno A, Saito M, Inoue T, Tsuchiya N, Satoh S, Habuchi T.  Altered miRNA expression in high-fat diet-induced prostate cancer progression  Carcinogenesis  2016  37(12):1129-1137  PubMed ID: 27915273   DOI: 10.1093/carcin/bgw108
7447  Sakane C, Ohta H, Shidoji Y.  Measurement of lysine-specific demethylase-1 activity in the nuclear extracts by flow-injection based time-of-flight mass spectrometry.  J Clin Biochem Nutr  2015  56:123-31  PubMed ID: 25759518   DOI: 10.3164/jcbn.14-99
12866  Okada T, Niiyama E, Uto K, Aoyagi T, Ebara M.  Inactivated Sendai Virus (HVJ-E) Immobilized Electrospun Nanofiber for Cancer Therapy  Materials (Basel)  2015  9(1):12  PubMed ID: 28787810   DOI: 10.3390/ma9010012
14955  Nishikawa Y, Okuzaki D, Fukushima K, Mukai S, Ohno S, Ozaki Y, Yabuta N, Nojima H.  Withaferin A Induces Cell Death Selectively in Androgen-Independent Prostate Cancer Cells but Not in Normal Fibroblast Cells  PLoS One  2015  10(7):e0134137  PubMed ID: 26230090   DOI: 10.1371/journal.pone.0134137
15159  Honda S, Loher P, Shigematsu M, Palazzo JP, Suzuki R, Imoto I, Rigoutsos I, Kirino Y.  Sex hormone-dependent tRNA halves enhance cell proliferation in breast and prostate cancers  Proc Natl Acad Sci U S A  2015  112(29):E3816-25  PubMed ID: 26124144   DOI: 10.1073/pnas.1510077112
15240  Kobayashi M, Kim SH, Nakamura H, Kaneda S, Fujii T.  Cancer Cell Analyses at the Single Cell-Level Using Electroactive Microwell Array Device  PLoS One  2015  10(11):e0139980  PubMed ID: 26558904   DOI: 10.1371/journal.pone.0139980
18179  Chiba S, Ikushima H, Ueki H, Yanai H, Kimura Y, Hangai S, Nishio J, Negishi H, Tamura T, Saijo S, Iwakura Y, Taniguchi T.  Recognition of tumor cells by Dectin-1 orchestrates innate immune cells for anti-tumor responses  Elife  2014  3:e04177  PubMed ID: 25149452   DOI: 10.7554/eLife.04177
6398  Nagano K, Yamashita T, Inoue M, Higashisaka K, Yoshioka Y, Abe Y, Mukai Y, Kamada H, Tsutsumi Y, Tsunoda S  Eph receptor A10 has a potential as a target for a prostate cancer therapy.  Biochem Biophys Res Commun  2014  450(1):545-9  PubMed ID: 24924629   DOI: 10.1016/j.bbrc.2014.06.007
16006  Ramesh V, Ananda Rao B, Sharma P, Swarna B, Thummuri D, Srinivas K, Naidu VG, Jayathirtha Rao V.  Synthesis and biological evaluation of new rhodanine analogues bearing 2-chloroquinoline and benzo[h]quinoline scaffolds as anticancer agents  Eur J Med Chem  2014  83:569-80  PubMed ID: 24996143   DOI: 10.1016/j.ejmech.2014.06.013
19527  The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy  The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy  Oncogene  2012  31(27):3254-64  PubMed ID: 22037214   DOI: 10.1038/onc.2011.489
16648  Konishi J, Yamazaki K, Yokouchi H, Shinagawa N, Iwabuchi K, Nishimura M.  The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients  Hum Immunol  2004  65(11):1377-88  PubMed ID: 15556688   DOI: 10.1016/j.humimm.2004.09.003
5547  Orui H, Imaizumi S, Ogino T, Motoyama T.  Effects of bone morphogenetic protein-2 on human tumor cell growth and differentiation: a preliminary report.  J Orthop Sci  2000  5(6):600-4  PubMed ID: 11180925   DOI: 10.1007/s007760070012
18568  Kato Y, Sakai N, Baba M, Kaneko S, Kondo K, Kubota Y, Yao M, Shuin T, Saito S, Koshika S, Kawase T, Miyagi Y, Aoki I, Nagashima Y.  Stimulation of motility of human renal cell carcinoma by SPARC/Osteonectin/BM-40 associated with type IV collagen  Invasion Metastasis  1998  18(2):105-14  PubMed ID: 10364690   DOI: 10.1159/000024503

11015    放射線刺激により誘発されるインターロイキン 34 の放射線治療抵抗性における潜在的役割について  聖マリアンナ医科大学雑誌  2017  45, 173-183    DOI: 10.14963/stmari.45.173

戻る 戻る 理研トップページへ